We Collected Blood Samples From Septic Shock Patients and Measured ELABELA, Creatinine, and NGAL Levels. Survival After 7 Days Was Recorded and Analyzed to Evaluate the Potential of Serum ELABELA as an Early Diagnostic Marker for Sepsis-associated Acute Kidney Injury.

Conditions:   Sepsis;   Septic Shock;   Acute Kidney Injury Intervention:   Sponsor:   Xiangcheng Zhang Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials